CMPX — Compass Therapeutics. Cashflow Statement
0.000.00%
Last trade - 00:00
- $222.89m
- $70.43m
- 40
- 30
- 49
- 34
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -34.7 | -29.5 | -82.2 | -39.2 | -42.5 |
Depreciation | |||||
Non-Cash Items | 1.14 | 4.94 | 55.7 | 5.58 | 4.08 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.257 | -4.65 | 6.25 | -1.26 | -2.91 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -31.7 | -26.8 | -19.7 | -34.1 | -40.6 |
Capital Expenditures | -0.466 | -0.106 | -1.89 | -0.212 | -0.03 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0.144 | 0.116 | -151 | 27 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.466 | 0.038 | -1.77 | -151 | 27 |
Financing Cash Flow Items | 0 | -6.32 | -0.281 | -0.495 | -0.253 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 48.5 | 119 | 75.8 | 2.94 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -32.2 | 21.8 | 97.2 | -110 | -10.7 |